Insulin syringes (29-31 gauge, 0.5-1ml capacity)
With respect to adverse events, the only complaints were injection site pain which affected four patients of those receiving thrice-weekly injections and one patient of those with once-weekly injections, as well as headache which affected one person in each group [19]
Yes, most lab work is completed directly at our Manteca clinic, allowing for faster results and a more streamlined experience
73% bioavailability via subcutaneous injection
Disclaimer: This article is for informational purposes only and does not replace professional medical advice
Since the introduction of insulin almost a century ago, more than 80 peptide drugs have reached the market for a wide range of diseases, including diabetes, cancer, osteoporosis, and multiple sclerosis (Muttenthaler et al., 2021)